APYX Shareholder News: Robbins LLP Reminds Investors of Class Action Lawsuit Against Apyx Medical Corporation (APYX)

SAN DIEGO–(BUSINESS WIRE)–The class: Law firm in shareholder law Robbins LLP reminds investors that a shareholder has filed a class action lawsuit on behalf of all persons or entities who purchased or otherwise acquired securities of Apyx Medical Corporation (NASDAQ: APYX) between May 12, 2021 and March 11, 2022, for violation of the Securities Exchange Act of 1934 Apyx claims to be an advanced energy technology company with products in the cosmetic and surgical markets. Nearly 80% of its turnover comes from the Advanced Energy segment.

If you would like more information about Apyx Medical Corporation’s misconduct, click here.

What this case is about: Apyx Medical Corporation (APYX) has used its products for off-label indications

According to the Complaint, during the Class Period, the Defendants failed to disclose to investors that a significant number of Apyx’s Advanced Energy products were used for off-label indications and that these off-label uses resulted in increased number of medical device reports. filed by Apyx reporting serious adverse events. Accordingly, the Company was reasonably likely to be subject to regulatory review, which would adversely affect its financial results.

On March 14, 2022, Apyx disclosed that the FDA would issue a Medical Device Safety Notice (“MDSC”) regarding the company’s advanced energy products. The Company further revealed that “[b]Based on our initial interactions with the FDA, we believe the Agency’s MDSC will relate to the use of our Advanced Energy products outside of their FDA-approved indication for general use in cutting, coagulation, and soft tissue removal during open and laparoscopic surgical procedures. .” On this news, shares of the company fell $4.02, or more than 40%, to close at $5.66 per share on March 14, 2022.

Next steps: If you acquired shares of Apyx Medical Corporation securities between May 12, 2021 and March 11, 2022, you have until August 5, 2022, to ask the court to name you as the lead plaintiff in the class. A lead plaintiff is a representative party acting on behalf of the other class members to direct the litigation. You don’t have to be in the case to be eligible for a clawback.

All representation is done on a contingent fee basis. Shareholders do not pay any fees or expenses.

Contact us for more information:

Aaron Dumas

(800) 350-6003

[email protected]

Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP are dedicated to helping shareholders recoup losses, improving corporate governance structures and holding corporate executives responsible for their wrongdoings since 2002. To be notified if a class action lawsuit against Apyx Medical Corporation settles or to receive free alerts when corporate executives commit wrongdoing, sign up for Watch Inventory today.

Lawyer advertisement. Past results do not guarantee a similar result.

Robert D. Coleman